Pengfei Wang

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Venues

Nature communications

Cell discovery

Journal of medical virology

Signal transduction and targeted therapy

Columbia University

Fudan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Columbia University Jan 01 2020

United States

Associate Research Scientist :: Aaron Diamond AIDS Research Center

Aaron Diamond Aids Research Center Aug 19 2015 - Dec 31 2019

United States

Postdoc

Education History

Fudan University Sep 01 2010 - Jul 01 2015

China

PHD :: State Key Laboratory of Genetic Engineering at Fudan University

Beijing Normal University Sep 01 2006 - Jul 01 2010

China

BSC :: College of Life Sciences

Publications

Chaoyue Zhao, Guonan Cai, Xing Zhang, Xinyu Liu, Pengfei Wang, Aihua Zheng
Comparative Analysis of Bisexual and Parthenogenetic Populations in Haemaphysalis Longicornis. Microorganisms 12 (4) (2024)
Jason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, Li Ou, Maple Wang, Xuejun Chen, Cheng Cheng, Andrea Biju, Yaping Sun, Pengfei Wang, Yongping Yang, Baoshan Zhang, Jeffrey C Boyington, Tatsiana Bylund, Sam Charaf, Steven J Chen, Haijuan Du, Amy R Henry, Tracy Liu, Edward K Sarfo, Chaim A Schramm, Chen-Hsiang Shen, Tyler Stephens, I-Ting Teng, John-Paul Todd, Yaroslav Tsybovsky, Raffaello Verardi, Danyi Wang, Shuishu Wang, Zhantong Wang, Cheng-Yan Zheng, Tongqing Zhou, Daniel C Douek, John R Mascola, David D Ho, Mitchell Ho, Peter D Kwong
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability. Nature communications 15 (1) (2024)
Xun Wang, Shujun Jiang, Wentai Ma, Yanliang Zhang, Pengfei Wang
Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies. Signal transduction and targeted therapy 9 (1) (2024)
Xun Wang, Meng Zhang, Kaifeng Wei, Chen Li, Jinghui Yang, Shujun Jiang, Chaoyue Zhao, Xiaoyu Zhao, Rui Qiao, Yuchen Cui, Yanjia Chen, Jiayan Li, Guonan Cai, Changyi Liu, Jizhen Yu, Wenhong Zhang, Faren Xie, Pengfei Wang, Yanliang Zhang
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection. Vaccines 12 (5) (2024)
Jason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, Li Ou, Maple Wang, Xuejun Chen, Cheng Cheng, Andrea Biju, Yaping Sun, Pengfei Wang, Yongping Yang, Baoshan Zhang, Jeffrey C Boyington, Tatsiana Bylund, Sam Charaf, Steven J Chen, Haijuan Du, Amy R Henry, Tracy Liu, Edward K Sarfo, Chaim A Schramm, Chen-Hsiang Shen, Tyler Stephens, I-Ting Teng, John-Paul Todd, Yaroslav Tsybovsky, Raffaello Verardi, Danyi Wang, Shuishu Wang, Zhantong Wang, Cheng-Yan Zheng, Tongqing Zhou, Daniel C Douek, John R Mascola, David D Ho, Mitchell Ho, Peter D Kwong
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability. Nature communications 15 (1) (2024)
Jason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, Li Ou, Maple Wang, Xuejun Chen, Cheng Cheng, Andrea Biju, Yaping Sun, Pengfei Wang, Yongping Yang, Baoshan Zhang, Jeffrey C Boyington, Tatsiana Bylund, Sam Charaf, Steven J Chen, Haijuan Du, Amy R Henry, Tracy Liu, Edward K Sarfo, Chaim A Schramm, Chen-Hsiang Shen, Tyler Stephens, I-Ting Teng, John-Paul Todd, Yaroslav Tsybovsky, Raffaello Verardi, Danyi Wang, Shuishu Wang, Zhantong Wang, Cheng-Yan Zheng, Tongqing Zhou, Daniel C Douek, John R Mascola, David D Ho, Mitchell Ho, Peter D Kwong
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability. Nature communications 15 (1) (2024)
Xun Wang, Shujun Jiang, Wentai Ma, Yanliang Zhang, Pengfei Wang
Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies. Signal transduction and targeted therapy 9 (1) (2024)
Jason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, Li Ou, Maple Wang, Xuejun Chen, Cheng Cheng, Andrea Biju, Yaping Sun, Pengfei Wang, Yongping Yang, Baoshan Zhang, Jeffrey C Boyington, Tatsiana Bylund, Sam Charaf, Steven J Chen, Haijuan Du, Amy R Henry, Tracy Liu, Edward K Sarfo, Chaim A Schramm, Chen-Hsiang Shen, Tyler Stephens, I-Ting Teng, John-Paul Todd, Yaroslav Tsybovsky, Raffaello Verardi, Danyi Wang, Shuishu Wang, Zhantong Wang, Cheng-Yan Zheng, Tongqing Zhou, Daniel C Douek, John R Mascola, David D Ho, Mitchell Ho, Peter D Kwong
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability. Nature communications 15 (1) (2024)
Chaoyue Zhao, Guonan Cai, Shuai Jiang, Xun Wang, Chen Li, Xinyu Liu, Rui Qiao, Xiaoyu Zhao, Yuchen Cui, Yanjia Chen, Jiayan Li, Changyi Liu, Jizhen Yu, Jiami Gong, Pengfei Wang
Broad-spectrum coronavirus neutralization induced by hetero RBD-Fc protein vaccine. Journal of medical virology 96 (9) (2024)
Xiaoyu Zhao, Tianyi Qiu, Xiner Huang, Qiyu Mao, Yajie Wang, Rui Qiao, Jiayan Li, Tiantian Mao, Yuan Wang, Yewei Cun, Caicui Wang, Cuiting Luo, Chaemin Yoon, Xun Wang, Chen Li, Yuchen Cui, Chaoyue Zhao, Minghui Li, Yanjia Chen, Guonan Cai, Wenye Geng, Zixin Hu, Jinglei Cao, Wenhong Zhang, Zhiwei Cao, Hin Chu, Lei Sun, Pengfei Wang
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination. Cell discovery 10 (1) (2024)
Jason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, Li Ou, Maple Wang, Xuejun Chen, Cheng Cheng, Andrea Biju, Yaping Sun, Pengfei Wang, Yongping Yang, Baoshan Zhang, Jeffrey C Boyington, Tatsiana Bylund, Sam Charaf, Steven J Chen, Haijuan Du, Amy R Henry, Tracy Liu, Edward K Sarfo, Chaim A Schramm, Chen-Hsiang Shen, Tyler Stephens, I-Ting Teng, John-Paul Todd, Yaroslav Tsybovsky, Raffaello Verardi, Danyi Wang, Shuishu Wang, Zhantong Wang, Cheng-Yan Zheng, Tongqing Zhou, Daniel C Douek, John R Mascola, David D Ho, Mitchell Ho, Peter D Kwong
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability. Nature communications 15 (1) (2024)
Xun Wang, Shujun Jiang, Wentai Ma, Yanliang Zhang, Pengfei Wang
Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies. Signal transduction and targeted therapy 9 (1) (2024)
Chaoyue Zhao, Guonan Cai, Xing Zhang, Xinyu Liu, Pengfei Wang, Aihua Zheng
Comparative Analysis of Bisexual and Parthenogenetic Populations in Haemaphysalis Longicornis. Microorganisms 12 (4) (2024)
Xiaoyu Zhao, Tianyi Qiu, Xiner Huang, Qiyu Mao, Yajie Wang, Rui Qiao, Jiayan Li, Tiantian Mao, Yuan Wang, Yewei Cun, Caicui Wang, Cuiting Luo, Chaemin Yoon, Xun Wang, Chen Li, Yuchen Cui, Chaoyue Zhao, Minghui Li, Yanjia Chen, Guonan Cai, Wenye Geng, Zixin Hu, Jinglei Cao, Wenhong Zhang, Zhiwei Cao, Hin Chu, Lei Sun, Pengfei Wang
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination. Cell discovery 10 (1) (2024)
Xiaoyu Zhao, Rui Qiao, Meng Hao, Longfa Xu, Dong Wang, Yinying Lu, Jiayan Li, Jing Wu, Yi Li, Tong Cheng, Wenhong Zhang, Jin-Cun Zhao, Pengfei Wang
Vascular endothelial growth factor receptor 2 as a potential host target for the inhibition of enterovirus replication. Journal of virology (2024)
Xun Wang, Meng Zhang, Kaifeng Wei, Chen Li, Jinghui Yang, Shujun Jiang, Chaoyue Zhao, Xiaoyu Zhao, Rui Qiao, Yuchen Cui, Yanjia Chen, Jiayan Li, Guonan Cai, Changyi Liu, Jizhen Yu, Wenhong Zhang, Faren Xie, Pengfei Wang, Yanliang Zhang
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection. Vaccines 12 (5) (2024)
Jason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, Li Ou, Maple Wang, Xuejun Chen, Cheng Cheng, Andrea Biju, Yaping Sun, Pengfei Wang, Yongping Yang, Baoshan Zhang, Jeffrey C Boyington, Tatsiana Bylund, Sam Charaf, Steven J Chen, Haijuan Du, Amy R Henry, Tracy Liu, Edward K Sarfo, Chaim A Schramm, Chen-Hsiang Shen, Tyler Stephens, I-Ting Teng, John-Paul Todd, Yaroslav Tsybovsky, Raffaello Verardi, Danyi Wang, Shuishu Wang, Zhantong Wang, Cheng-Yan Zheng, Tongqing Zhou, Daniel C Douek, John R Mascola, David D Ho, Mitchell Ho, Peter D Kwong
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability. Nature communications 15 (1) (2024)
Xun Wang, Xing He, Shujun Jiang, Zhangfan Fu, Shuai Jiang, Xiaoyu Zhao, Chaoyue Zhao, Yaning Li, Dianfan Li, Wenhong Zhang, Jingwen Ai, Yanliang Zhang, Chenqi Xu, Pengfei Wang
Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection. Journal of medical virology (2023)
Xun Wang, Xing He, Shujun Jiang, Zhangfan Fu, Shuai Jiang, Xiaoyu Zhao, Chaoyue Zhao, Yaning Li, Dianfan Li, Wenhong Zhang, Jingwen Ai, Yanliang Zhang, Chenqi Xu, Pengfei Wang
Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection. Journal of medical virology 95 (2) (2023)
Xun Wang, Xing He, Shujun Jiang, Zhangfan Fu, Shuai Jiang, Xiaoyu Zhao, Chaoyue Zhao, Yaning Li, Dianfan Li, Wenhong Zhang, Jingwen Ai, Yanliang Zhang, Chenqi Xu, Pengfei Wang
Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection. Journal of medical virology 95 (2) (2023)
Xun Wang, Shuai Jiang, Shujun Jiang, Xiangnan Li, Jingwen Ai, Ke Lin, Shiyun Lv, Shixuan Zhang, Minghui Li, Jixi Li, Lili Dai, Zixin Hu, Wenhong Zhang, Yanliang Zhang, Pengfei Wang
Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from previous and recent waves in China. Cell discovery 9 (1) (2023)
Xun Wang, Minghui Li, Panpan Lu, Chen Li, Chaoyue Zhao, Xiaoyu Zhao, Rui Qiao, Yuchen Cui, Yanjia Chen, Jiayan Li, Guonan Cai, Pengfei Wang
In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG. Pathogens (Basel, Switzerland) 12 (9) (2023)
Aihua Hao, Wenping Song, Cheng Li, Xiang Zhang, Chao Tu, Xun Wang, Pengfei Wang, Yanling Wu, Tianlei Ying, Lei Sun
Defining a highly conserved cryptic epitope for antibody recognition of SARS-CoV-2 variants. Signal transduction and targeted therapy 8 (1) (2023)
Xun Wang, Shuai Jiang, Shujun Jiang, Xiangnan Li, Jingwen Ai, Ke Lin, Shiyun Lv, Shixuan Zhang, Minghui Li, Jixi Li, Lili Dai, Zixin Hu, Wenhong Zhang, Yanliang Zhang, Pengfei Wang
Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from previous and recent waves in China. Cell discovery 9 (1) (2023)
Xun Wang, Xiaoyu Zhao, Jieyu Song, Jing Wu, Yuqi Zhu, Minghui Li, Yuchen Cui, Yanjia Chen, Lulu Yang, Jun Liu, Huanzhang Zhu, Shibo Jiang, Pengfei Wang
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies. Emerging microbes & infections 11 (1) (2022)
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, Huanzhang Zhu, Shibo Jiang, Pengfei Wang
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nature reviews. Immunology (2022)
Xun Wang, Jingwen Ai, Xiangnan Li, Xiaoyu Zhao, Jing Wu, Haocheng Zhang, Xing He, Chaoyue Zhao, Rui Qiao, Minghui Li, Yuchen Cui, Zixin Hu, Chenqi Xu, Wenhong Zhang, Pengfei Wang
Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera. Cell discovery 8 (1) (2022)
Marciela M DeGrace, Elodie Ghedin, Matthew B Friemann, Florian Krammer, Alba Grifoni, Arghavan Alisoltani, Galit Alter, Rama Rao Amara, Ralph S Baric, Dan H Barouch, Jesse D Bloom, Louis-Marie Bloyet, Gaston Bonenfant, Adrianus C M Boon, Eli A Boritz, Debbie L Bratt, Traci L Bricker, Liliana Brown, William J Buchser, Juan Manuel Carreño, Liel Cohen-Lavi, Tamarand L Darling, Meredith E Davis-Gardner, Bethany L Dearlove, Han Di, Meike Dittmann, Nicole A Doria-Rose, Daniel C Douek, Christian Drosten, Venkata-Viswanadh Edara, Ali H Ellebedy, Thomas P Fabrizio, Guido Ferrari, Will M Fischer, William C Florence, Ron A M Fouchier, John Franks, Adolfo García-Sastre, Adam Godzik, Ana Silvia Gonzalez-Reiche, Aubree Gordon, Bart L Haagmans, Peter J Halfmann, David D Ho, Michael R Holbrook, Yaoxing Huang, Sarah L James, Lukasz Jaroszewski, Trushar Jeevan, Robert M Johnson, Terry C Jones, Astha Joshi, Yoshihiro Kawaoka, Lisa Kercher, Marion P G Koopmans, Bette T Korber, Eilay Koren, Richard A Koup, Eric B LeGresley, Jacob E Lemieux, Mariel J Liebeskind, Zhuoming Liu, Brandi Livingston, James P Logue, Yang Luo, Adrian B McDermott, Margaret J McElrath, Victoria A Meliopoulos, Vineet D Menachery, David C Montefiori, Barbara Mühlemann, Vincent J Munster, Jenny E Munt, Manoj S Nair, Antonia Netzl, Anna M Niewiadomska, Sijy O'Dell, Andrew S Pekosz, Stanley Perlman, Marjorie C Pontelli, Barry Rockx, Morgane Rolland, Paul W Rothlauf, Sinai Sacharen, Richard H Scheuermann, Stephen D Schmidt, Michael Schotsaert, Stacey Schultz-Cherry, Robert A Seder, Mayya Sedova, Alessandro Sette, Reed S Shabman, Xiaoying Shen, Pei-Yong Shi, Maulik Shukla, Viviana Simon, Spencer Stumpf, Nancy J Sullivan, Larissa B Thackray, James Theiler, Paul Glyndwr Thomas, Sanja Trifkovic, Sina Türeli, Samuel A Turner, Maria A Vakaki, Harm van Bakel, Laura A VanBlargan, Leah R Vincent, Zachary S Wallace, Li Wang, Maple Wang, Pengfei Wang, Wei Wang, Scott C Weaver, Richard John Webby, Carol D Weiss, David E Wentworth, Stuart M Weston, Sean P J Whelan, Bradley M Whitener, Samuel H Wilks, Xuping Xie, Baoling Ying, Hyejin Yoon, Bin Zhou, Tomer Hertz, Derek J Smith, Michael S. Diamond, Diane J Post, Mehul S Suthar
Defining the risk of SARS-CoV-2 variants on immune protection. Nature 605 (7911) (2022)
Pengfei Wang, Ryan G Casner, Manoj S Nair, Jian Yu, Yicheng Guo, Maple Wang, Jasper F-W Chan, Gabriele Cerutti, Sho Iketani, Lihong Liu, Zizhang Sheng, Zhiwei Chen, Kwok-Yung Yuen, Peter D Kwong, Yaoxing Huang, Lawrence Shapiro, David D Ho
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses. Emerging microbes & infections (2021)
Pengfei Wang, Mili R Gajjar, Jian Yu, Neal N Padte, Agegnehu Gettie, James L Blanchard, Kasi E Russell-Lodrigue, Laura E Liao, Alan S Perelson, Yaoxing Huang, David D Ho
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo. Proceedings of the National Academy of Sciences of the United States of America 117 (30) (2020)
Pengfei Wang, Lihong Liu, Manoj S Nair, Michael T Yin, Yang Luo, Qian Wang, Ting Yuan, Kanako Mori, Axel Guzman Solis, Masahiro Yamashita, Ankur Garg, Lawrence J Purpura, Justin C Laracy, Jian Yu, Leemor Joshua-Tor, Joseph Sodroski, Yaoxing Huang, David D Ho
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease. Emerging microbes & infections 9 (1) (2020)
Pengfei Wang, Panpan Lu, Xiying Qu, Yinzhong Shen, Hanxian Zeng, Xiaoli Zhu, Yuqi Zhu, Xian Li, Hao Wu, Jianqing Xu, Hongzhou Lu, Zhongjun Ma, Huanzhang Zhu
Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui. Scientific reports 7 (1) (2017)

Pengfei Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pengfei Wang